• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻咽癌细胞系 C666-1 中 Epstein-Barr 病毒的完整基因组序列。

Complete genomic sequence of Epstein-Barr virus in nasopharyngeal carcinoma cell line C666-1.

机构信息

Department of Computer Science and Engineering, The Chinese University of Hong Kong, Hong Kong SAR, China.

Department of Anatomical and Cellular Pathology, State Key Laboratory in Oncology in South China, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.

出版信息

Infect Agent Cancer. 2013 Aug 2;8(1):29. doi: 10.1186/1750-9378-8-29.

DOI:10.1186/1750-9378-8-29
PMID:23915735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3734220/
Abstract

BACKGROUND

Nasopharyngeal carcinoma is a distinct type of head and neck cancer which is consistently associated with Epstein-Barr virus (EBV). The C666-1 cell line is the only in vitro native EBV-infected NPC cell model commonly used for study of the viral-host interaction. Nevertheless, the complete EBV genome sequence in this in vitro EBV-infected NPC model has not been characterized.

OBJECTIVE

To determine the complete EBV genome sequence in C666-1 cells.

METHODS

The C666-1 genome was sequenced by 100-bases pair-end massive parallel sequencing. Bioinformatics analysis was performed to extract the EBV sequences and construct an EBV consensus sequence map. PCR amplification and Sanger DNA sequencing were used for sequence validation and gap filling. A phylogenetic analysis of EBV strain in C666-1 cells and other reported EBV strains was performed.

RESULTS

A 171,317 bp complete EBV genome of C666-1 was successfully constructed (GenBank accession number: KC617875). Phylogenetic analysis of EBV genome in C666-1 revealed that the C666-1 EBV strain is closely related to the reported strains in NPC primary tumors.

CONCLUSION

C666-1 contains a representative NPC-associated EBV genome and might serve as an important model for studying the roles or function of viral proteins in NPC tumorigenesis.

摘要

背景

鼻咽癌是一种独特的头颈部癌症,与 Epstein-Barr 病毒(EBV)密切相关。C666-1 细胞系是唯一常用的体外天然 EBV 感染 NPC 细胞模型,用于研究病毒-宿主相互作用。然而,该体外 EBV 感染 NPC 模型中的完整 EBV 基因组序列尚未得到描述。

目的

确定 C666-1 细胞中的完整 EBV 基因组序列。

方法

通过 100 碱基对末端大规模平行测序对 C666-1 基因组进行测序。生物信息学分析用于提取 EBV 序列并构建 EBV 共识序列图谱。PCR 扩增和 Sanger DNA 测序用于序列验证和缺口填充。对 C666-1 细胞中的 EBV 株与其他报道的 EBV 株进行系统发育分析。

结果

成功构建了 171317bp 的 C666-1 完整 EBV 基因组(GenBank 登录号:KC617875)。C666-1 中 EBV 基因组的系统发育分析表明,C666-1 EBV 株与报道的 NPC 原发性肿瘤中的株密切相关。

结论

C666-1 含有具有代表性的 NPC 相关 EBV 基因组,可能成为研究病毒蛋白在 NPC 肿瘤发生中的作用或功能的重要模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e861/3734220/c79611ec1be1/1750-9378-8-29-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e861/3734220/fbe31812a95c/1750-9378-8-29-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e861/3734220/c79611ec1be1/1750-9378-8-29-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e861/3734220/fbe31812a95c/1750-9378-8-29-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e861/3734220/c79611ec1be1/1750-9378-8-29-2.jpg

相似文献

1
Complete genomic sequence of Epstein-Barr virus in nasopharyngeal carcinoma cell line C666-1.鼻咽癌细胞系 C666-1 中 Epstein-Barr 病毒的完整基因组序列。
Infect Agent Cancer. 2013 Aug 2;8(1):29. doi: 10.1186/1750-9378-8-29.
2
Genome-wide Analysis of Epstein-Barr Virus (EBV) Integration and Strain in C666-1 and Raji Cells.C666-1和Raji细胞中爱泼斯坦-巴尔病毒(EBV)整合及毒株的全基因组分析
J Cancer. 2016 Jan 1;7(2):214-24. doi: 10.7150/jca.13150. eCollection 2016.
3
Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy.从原发性鼻咽癌活检中分离的 Epstein-Barr 病毒基因组的基因组测序和比较分析。
PLoS One. 2012;7(5):e36939. doi: 10.1371/journal.pone.0036939. Epub 2012 May 10.
4
Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology.应用下一代测序技术对鼻咽癌组织中 Epstein-Barr 病毒临床分离株进行直接测序和特征分析。
J Virol. 2011 Nov;85(21):11291-9. doi: 10.1128/JVI.00823-11. Epub 2011 Aug 31.
5
Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.持续携带爱泼斯坦-巴尔病毒的鼻咽癌细胞系(C666-1)
Int J Cancer. 1999 Sep 24;83(1):121-6. doi: 10.1002/(sici)1097-0215(19990924)83:1<121::aid-ijc21>3.0.co;2-f.
6
Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.对从原发性鼻咽癌活检标本中分离出的18株爱泼斯坦-巴尔病毒进行全基因组分析。
J Virol. 2017 Aug 10;91(17). doi: 10.1128/JVI.00301-17. Print 2017 Sep 1.
7
Integrated mRNA and microRNA transcriptome sequencing characterizes sequence variants and mRNA-microRNA regulatory network in nasopharyngeal carcinoma model systems.整合的 mRNA 和 microRNA 转录组测序描绘了鼻咽癌模型系统中的序列变异和 mRNA-microRNA 调控网络。
FEBS Open Bio. 2014 Jan 13;4:128-40. doi: 10.1016/j.fob.2014.01.004. eCollection 2014.
8
[Effect of exosomes derived from human Epstein-Barr virus-positive nasopharyngeal carcinoma cells on lymphangiogenesis and lymph node metastasis].[人EB病毒阳性鼻咽癌细胞来源的外泌体对淋巴管生成及淋巴结转移的影响]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Dec 30;40(12):1776-1783. doi: 10.12122/j.issn.1673-4254.2020.12.12.
9
Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.EBV 相关鼻咽癌中不同 NF-κB 信号的组成性激活。
J Pathol. 2013 Nov;231(3):311-22. doi: 10.1002/path.4239. Epub 2013 Sep 3.
10
NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.NF-κB信号传导调节鼻咽癌中爱泼斯坦-巴尔病毒BART微小RNA和长链非编码RNA的表达。
J Virol. 2016 Jun 24;90(14):6475-88. doi: 10.1128/JVI.00613-16. Print 2016 Jul 15.

引用本文的文献

1
CRISPR/Cas13-Mediated Inhibition of EBNA1 for Suppression of Epstein-Barr Virus Transcripts and DNA Load in Nasopharyngeal Carcinoma Cells.CRISPR/Cas13介导的EBNA1抑制对鼻咽癌细胞中EB病毒转录本和DNA载量的抑制作用
Viruses. 2025 Jun 26;17(7):899. doi: 10.3390/v17070899.
2
Identification of HLA-A*11:01 and A*02:01-Restricted EBV Peptides Using HLA Peptidomics.利用 HLA 肽组学鉴定 HLA-A*11:01 和 A*02:01 限制性 EBV 肽
Viruses. 2024 Apr 25;16(5):669. doi: 10.3390/v16050669.
3
The role of Epstein-Barr virus in nasopharyngeal carcinoma.

本文引用的文献

1
Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy.从原发性鼻咽癌活检中分离的 Epstein-Barr 病毒基因组的基因组测序和比较分析。
PLoS One. 2012;7(5):e36939. doi: 10.1371/journal.pone.0036939. Epub 2012 May 10.
2
Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches.通过分子、细胞遗传学和表观遗传学方法揭示 NPC 的分子遗传基础。
Semin Cancer Biol. 2012 Apr;22(2):79-86. doi: 10.1016/j.semcancer.2011.12.011. Epub 2012 Jan 10.
3
A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.
爱泼斯坦-巴尔病毒在鼻咽癌中的作用。
Front Microbiol. 2023 Feb 9;14:1116143. doi: 10.3389/fmicb.2023.1116143. eCollection 2023.
4
Accurate reconstruction of viral genomes in human cells from short reads using iterative refinement.利用迭代细化技术,从短读长序列中准确重建人类细胞中的病毒基因组。
BMC Genomics. 2022 Jun 6;23(1):422. doi: 10.1186/s12864-022-08649-8.
5
Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma Carcinogenesis.爱泼斯坦-巴尔病毒介导的信号传导在鼻咽癌发生中的作用
Cancers (Basel). 2020 Aug 28;12(9):2441. doi: 10.3390/cancers12092441.
6
The Kaposi's Sarcoma-Associated Herpesvirus Protein ORF42 Is Required for Efficient Virion Production and Expression of Viral Proteins.卡波西肉瘤相关疱疹病毒蛋白 ORF42 是病毒粒子产生和病毒蛋白表达所必需的。
Viruses. 2019 Aug 2;11(8):711. doi: 10.3390/v11080711.
7
A reliable Epstein-Barr Virus classification based on phylogenomic and population analyses.基于系统发生基因组学和群体分析的可靠 Epstein-Barr 病毒分类。
Sci Rep. 2019 Jul 8;9(1):9829. doi: 10.1038/s41598-019-45986-3.
8
Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma.基因组测序分析鉴定与鼻咽癌高危相关的 Epstein-Barr 病毒亚型。
Nat Genet. 2019 Jul;51(7):1131-1136. doi: 10.1038/s41588-019-0436-5. Epub 2019 Jun 17.
9
Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.从结外 NK/T 细胞淋巴瘤,鼻型中分离的 Epstein-Barr 病毒的全基因组分析。
Oncologist. 2019 Sep;24(9):e905-e913. doi: 10.1634/theoncologist.2017-0588. Epub 2019 Apr 2.
10
Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma.建立并鉴定源自 EBV 阳性鼻咽癌的新型肿瘤异种移植物和癌细胞系。
Nat Commun. 2018 Nov 7;9(1):4663. doi: 10.1038/s41467-018-06889-5.
全基因组和转录组测序揭示肺腺癌中存在一个转化的 KIF5B 和 RET 基因融合。
Genome Res. 2012 Mar;22(3):436-45. doi: 10.1101/gr.133645.111. Epub 2011 Dec 22.
4
EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription.EBV 衣壳蛋白 BNRF1 破坏 DAXX-ATRX 以激活病毒早期基因转录。
PLoS Pathog. 2011 Nov;7(11):e1002376. doi: 10.1371/journal.ppat.1002376. Epub 2011 Nov 10.
5
Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology.应用下一代测序技术对鼻咽癌组织中 Epstein-Barr 病毒临床分离株进行直接测序和特征分析。
J Virol. 2011 Nov;85(21):11291-9. doi: 10.1128/JVI.00823-11. Epub 2011 Aug 31.
6
Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22.通过新鉴定的 Epstein-Barr 病毒编码 microRNA miR-BART22 对 LMP2A 表达的调节。
Neoplasia. 2009 Nov;11(11):1174-84. doi: 10.1593/neo.09888.
7
Modulation of LMP1 protein expression by EBV-encoded microRNAs.EBV编码的微小RNA对LMP1蛋白表达的调控
Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16164-9. doi: 10.1073/pnas.0702896104. Epub 2007 Oct 2.
8
Epstein-Barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes.爱泼斯坦-巴尔病毒BNRF1蛋白可使原代B淋巴细胞从内体区室高效转运至细胞核。
J Virol. 2006 Oct;80(19):9435-43. doi: 10.1128/JVI.00473-06.
9
Potential selection of LMP1 variants in nasopharyngeal carcinoma.鼻咽癌中LMP1变异体的潜在选择
J Virol. 2004 Jan;78(2):868-81. doi: 10.1128/jvi.78.2.868-881.2004.
10
Re: Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus.回复:肿瘤及非肿瘤相关的爱泼斯坦-巴尔病毒中BZLF1启动子的离散改变
J Natl Cancer Inst. 2003 Jul 2;95(13):1008-9; author reply 1009. doi: 10.1093/jnci/95.13.1008.